You have access
Clinical Impact of Primary Tumor Location and RAS, BRAF V600E, and PIK3CA Mutations on Epidermal Growth Factor Receptor Inhibitor Efficacy as Third-line Chemotherapy for Metastatic Colorectal Cancer
TARO SATO, HIROKI OSUMI, EIJI SHINOZAKI, AKIRA OOKI, KEITARO SHIMOZAKI, DAISAKU KAMIIMABEPPU, IZUMA NAKAYAMA, TAKERU WAKATSUKI, MARIKO OGURA, DAISUKE TAKAHARI, KEISHO CHIN and KENSEI YAMAGUCHI
Anticancer Research August 2021, 41 (8) 3905-3915; DOI: https://doi.org/10.21873/anticanres.15186